"The Company entered into a letter agreement to conduct a due diligence review of the proposed business of Vodis Innovative Pharmaceuticals Inc. (?VODIS?). VODIS has made an application to Health Canada to become a Licensed Producer under the Medical Purposes Regulation and intends to acquire all of the operating assets of 934145 BC Ltd. (?BC Ltd?) which is currently in production under the previous Health Canada regulations. The Company has provided an interest-free loan to BC Ltd. Of $250,000 (?Loan?) and has agreed to provide an additional $250,000 upon closing of the acquisition to complete the upgrading to the current production facilities. In the event that the transaction does not close, the Loan is repayable within 3 months. The acquisition agreement contemplates that the Company will change its name to VODIS and will issue 36 million common shares, subject to an escrow agreement, to the principals of VODIS and acquire the Assets for one dollar, and repay the loans outstanding to the shareholders of BC Ltd. in the amount of $500,000."
Quelle: sedar.com; May 30 2014; Interim financial statements/report
Naja, zum Dollar kommt in Währung das zinslose Darlehen für die Fabrik...
36.000.000 common shares...? Empfehle die Vereinbarungen genauer zu studieren, wer mehr Geld investiert hat oder noch möchte. ;-)
|